1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Enteral and Parenteral Medical Nutrition Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Enteral and Parenteral Medical Nutrition Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Rising Number of Gastrointestinal Diseases in geriatric population is propelling the market growth
5.2 Market Opportunities
- 5.2.1 Increasing Cases of Malnutrition and Premature Births in emerging nations is augmenting the demand for enteral and parenteral nutrition products
5.3 Future Trends
- 5.3.1 Growing Strategic Initiatives by Key Companies
5.4 Impact of Drivers and Restraints
6. Europe Enteral and Parenteral Medical Nutrition Market Regional Analysis
6.1 Europe Enteral and Parenteral Medical Nutrition Market Overview
6.2 Europe Enteral and Parenteral Medical Nutrition Market Revenue 2021-2028 (US$ Million)
6.3 Europe Enteral and Parenteral Medical Nutrition Market Forecast Analysis
7. Europe Enteral and Parenteral Medical Nutrition Market Analysis – by Indication
7.1 Elderly
- 7.1.1 Overview
- 7.1.2 Elderly: Europe Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Gastrointestinal Disorders
- 7.2.1 Overview
- 7.2.2 Gastrointestinal Disorders: Europe Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Diabetes
- 7.3.1 Overview
- 7.3.2 Diabetes: Europe Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Cancer
- 7.4.1 Overview
- 7.4.2 Cancer: Europe Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Respiratory Disorders
- 7.5.1 Overview
- 7.5.2 Respiratory Disorders: Europe Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Alzheimer's Disease
- 7.6.1 Overview
- 7.6.2 Alzheimer's Disease: Europe Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Dementia
- 7.7.1 Overview
- 7.7.2 Dementia: Europe Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Renal Disease
- 7.8.1 Overview
- 7.8.2 Renal Disease: Europe Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.9 Liver Failure
- 7.9.1 Overview
- 7.9.2 Liver Failure: Europe Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.10 Post COVID-19
- 7.10.1 Overview
- 7.10.2 Post COVID-19: Europe Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.11 Other Indications
- 7.11.1 Overview
- 7.11.2 Other Indications: Europe Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Enteral and Parenteral Medical Nutrition Market Analysis – by Nutrition Type
8.1 Supplemental
- 8.1.1 Overview
- 8.1.2 Supplemental: Europe Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Sole Source
- 8.2.1 Overview
- 8.2.2 Sole Source: Europe Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Enteral and Parenteral Medical Nutrition Market Analysis – by Form
9.1 Liquid
- 9.1.1 Overview
- 9.1.2 Sole Source: Europe Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Powder
- 9.2.1 Overview
- 9.2.2 Sole Source: Europe Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Semi Solid
- 9.3.1 Overview
- 9.3.2 Sole Source: Europe Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Enteral and Parenteral Medical Nutrition Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe Enteral and Parenteral Medical Nutrition Market Breakdown, by Key
Country, 2024 and 2028 (%)
- 10.1.1.1 Europe Enteral and Parenteral Medical Nutrition Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 UK: Europe Enteral and Parenteral Medical Nutrition Market Breakdown, by Indication
- 10.1.1.1.2 UK: Europe Enteral and Parenteral Medical Nutrition Market Breakdown, by Nutrition Type
- 10.1.1.1.3 UK: Europe Enteral and Parenteral Medical Nutrition Market Breakdown, by Form
- 10.1.1.2 Germany:
Europe Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Germany: Europe Enteral and Parenteral Medical Nutrition Market Breakdown, by Indication
- 10.1.1.2.2 Germany: Europe Enteral and Parenteral Medical Nutrition Market Breakdown, by Nutrition Type
- 10.1.1.2.3 Germany: Europe Enteral and Parenteral Medical Nutrition Market Breakdown, by Form
- 10.1.1.3 France:
Europe Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 France: Europe Enteral and Parenteral Medical Nutrition Market Breakdown, by Indication
- 10.1.1.3.2 France: Europe Enteral and Parenteral Medical Nutrition Market Breakdown, by Nutrition Type
- 10.1.1.3.3 France: Europe Enteral and Parenteral Medical Nutrition Market Breakdown, by Form
- 10.1.1.4 Russia:
Europe Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.1 Russia: Europe Enteral and Parenteral Medical Nutrition Market Breakdown, by Indication
- 10.1.1.4.2 Russia: Europe Enteral and Parenteral Medical Nutrition Market Breakdown, by Nutrition Type
- 10.1.1.4.3 Russia: Europe Enteral and Parenteral Medical Nutrition Market Breakdown, by Form
- 10.1.1.5 Italy:
Europe Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.5.1 Italy: Europe Enteral and Parenteral Medical Nutrition Market Breakdown, by Indication
- 10.1.1.5.2 Italy: Europe Enteral and Parenteral Medical Nutrition Market Breakdown, by Nutrition Type
- 10.1.1.5.3 Italy: Europe Enteral and Parenteral Medical Nutrition Market Breakdown, by Form
- 10.1.1.6 Rest of Europe:
Europe Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe Enteral and Parenteral Medical Nutrition Market Breakdown, by Indication
- 10.1.1.6.2 Rest of Europe: Europe Enteral and Parenteral Medical Nutrition Market Breakdown, by Nutrition Type
- 10.1.1.6.3 Rest of Europe: Europe Enteral and Parenteral Medical Nutrition Market Breakdown, by Form
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe Enteral and Parenteral Medical Nutrition Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 AYMES International Ltd
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 B. Braun SE
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Baxter International Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Charing Cross Scientific AS
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Fresenius Kabi AG
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Medifood International SA
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Nestle SA
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Nutricia International BV
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Smartfish AS
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights